Cytotoxic T cell mechanisms of β cell destruction in non-obese diabetic mice

Novartis Foundation Symposium

Volumn 292, Issue , 2008, Pages 68-78

  Kay, Thomas W H ^a   Dudek, Nadine L ^a   Graham, Kate ^a   Estella, Eugene ^a   Angstetra, Eveline ^a   McKenzie, Mark D ^a   Allison, Jan ^a   Thomas, Helen E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAS ANTIGEN; PERFORIN;

ANIMAL; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE MODEL; GENETICS; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PATHOLOGY;

ANIMALS; ANTIGENS, CD95; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; INSULIN-SECRETING CELLS; MICE; MICE, INBRED NOD; PERFORIN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 56249097898     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (41)

1. Allison J, Strasser A 1998 Mechanisms of beta cell death in diabetes: a minor role for CD95. Proc Natl Acad Sci USA 95:13818-13822
2. Allison J, Thomas HE Catterall T, Kay TW, Strasser A 2005 Transgenic expression of dominant-negative Fas-associated death domain protein in beta cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice. J Immunol 175:293-301
3. Amrani A, Verdaguer J, Anderson B, Utsugi T, Bou S, Santamaria P 1999 Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice. J Clin Invest 103:1201-1209
4. Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P 2000 IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. J Clin Invest 105:459-468
5. Apostolou I, Hao Z, Rajewsky K, von Boehmer H 2003 Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes. J Exp Med 198:1103-1106
6. Cantor J, Haskins K 2005 Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha. J Immunol 175:7738-7745
7. Chen Y, Chong MM, Darwiche R, Thomas HE, Kay TW 2004 Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency. Am J Pathol 165:913-921
8. Chervonsky AV, Wang Y, Wong FS et al 1997 The role of Fas in autoimmune diabetes. Cell 89:17-24
9. Chong MM, Thomas HE, Kay TW 2002 Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumor necrosis factor. J Biol Chem 277:27945-27952
10. Chong MM, Cornish AL, Darwiche R et al 2003 Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. Immunity 18:475-487
11. Chong MM, Chen Y, Darwiche R et al 2004 Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction. J Immunol 172:5714-5721
12. Christianson SW, Shultz LD, Leiter EH 1993 Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 42:44-55
13. Darwiche R, Chong MM, Santamaria P, Thomas HE, Kay TW 2003 Fas is detectable on beta cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice. J Immunol 170:6292-6297
14. Dudek NL, Thomas HE, Mariana L et al 2006 Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways. Diabetes 55:2412-2418
15. Estella E, McKenzie MD, Catterall T et al 2006 Granzyme B-mediated death of pancreatic beta-cells requires the proapoptotic BH3-only molecule bid. Diabetes 55:2212-2219
16. Graser RT, DiLorenzo TP, Wang F et al 2000 Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol 164:3913-3918
17. Hamilton-Williams EE, Palmer SE, Charlton B, Slattery RM 2003 Beta cell MHC class I is a late requirement for diabetes. Proc Natl Acad Sci USA 100:6688-6693
18. Hultgren B, Huang X, Dybdal N, Stewart TA 1996 Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45:812-817
19. Irawaty W, Kay TW, Thomas HE 2002 Transmembrane TNF and IFNgamma induce caspase-independent death of primary mouse pancreatic beta cells. Autoimmunity 35:369-375
20. Kagi D, Odermatt B, Seiler P, Zinkernagel RM, Mak TW, Hengartner H 1997 Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med 186:989-997
21. Kanagawa O, Xu G, Tevaarwerk A, Vaupel BA 2000 Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci. J Immunol 164: 3919-3923
22. Katz J, Benoist C, Mathis D 1993 Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol 23:3358-3360
23. Kay TW, Parker JL, Stephens LA, Thomas HE, Allison J 1996 RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null non-obese diabetic mice. J Immunol 157:3688-3693
24. Kim HS, Kim S, Lee MS 2005 IFN-gamma sensitizes MIN6N8 insulinoma cells to TNF-alpha-induced apoptosis by inhibiting NF-kappaB-mediated XIAP upregulation. Biochem Biophys Res Commun 336:847-853
25. Kim S, Millet I, Kim HS et al 2007 NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci USA 104:1913-1918
26. Leiter EH 2002 Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions. Diabetologia 45:296-308
27. Liuwantara D, Elliot M, Smith MW et al 2006 Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection. Diabetes 55:2491-2501
28. Miller BJ, Appel MC, O'Neil JJ, Wicker LS 1988 Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 140:52-58
29. O'Sullivan BJ, Thomas HE, Pai S et al 2006 IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol 176:7278-7287
30. Sandberg JO, Eizirik DL, Sandler S 1997 IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice. Clin Exp Immunol 108:314-317
31. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA 1988 Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52:773-782
32. Savinov AY, Tcherepanov A, Green EA, Flavell RA, Chervonsky AV 2003 Contribution of Fas to diabetes development. Proc Natl Acad Sci USA 100:628-632
33. Serreze DV, Leiter EH, Christianson GJ, Greiner D, Roopenian DC 1994 Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 43:505-509
34. Serreze DV, Post CM, Chapman HD, Johnson EA, Lu B, Rothman PB 2000 Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes 49:2007-2011
35. Thomas HE, Parker JL, Schreiber RD, Kay TW 1998 IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J Clin Invest 102:1249-1257
36. Thomas HE, Irawaty W, Darwiche R et al 2004 IL-1 receptor deficiency slows progression to diabetes in the NOD mouse. Diabetes 53:113-121
37. Thomas HE, Angstetra E, Fernandes RV et al 2006 Perturbations in nuclear factor-kappaB or c-Jun N-terminal kinase pathways in pancreatic beta cells confer susceptibility to cytokine-induced cell death. Immunol Cell Biol 84:20-27
38. Trapani JA, Smyth MJ 2002 Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2:735-747
39. Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P 1997 Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 186: 1663-1676
40. Wicker LS, Leiter EH, Todd JA et al 1994 Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43:500-504
41. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA Jr 1996 CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 183:67-76